AlphaYouCM
Congress trade
Rep. Carol Miller (R-WV) sold $15K-$50K of Gilead Sciences, Inc. (GILD) stock
Carol Miller, U.S. Representative (R-WV), disclosed a sale of Gilead Sciences, Inc. (GILD) stock worth $15K-$50K in a STOCK Act filing on Sep 2, 2022.
The trade happened on Nov 10, 2021, 296 days before it was made public.
GILD has moved +115.0% since the trade date, from $67.32 to $144.74 (Oct 2, 2026 close).
- Traded
- Nov 10, 2021
- Disclosed
- Sep 2, 2022
- Filing delay
- 296 days
- Price since
- +115.0%
- Source
- STOCK Act disclosure
Other trades in this disclosure (24)
- BuyAMGN$15K-$50KSep 2, 2022
- BuyBLK$15K-$50KSep 2, 2022
- SellBMY$15K-$50KSep 2, 2022
- BuyCLX$15K-$50KSep 2, 2022
- SellD$15K-$50KSep 2, 2022
- BuyDGX$15K-$50KSep 2, 2022
- BuyGD$15K-$50KSep 2, 2022
- SellHRL$15K-$50KSep 2, 2022
- BuyJNJ$15K-$50KSep 2, 2022
- SellLHX$15K-$50KSep 2, 2022
- SellMRK$15K-$50KSep 2, 2022
- BuyTXN$15K-$50KSep 2, 2022
- BuyVIAC$15K-$50KSep 2, 2022
- BuyABT$1K-$15KSep 2, 2022
- BuyAMGN$1K-$15KSep 2, 2022
- BuyCLX$1K-$15KSep 2, 2022
- BuyCSCO$1K-$15KSep 2, 2022
- BuyD$1K-$15KSep 2, 2022
- BuyD$1K-$15KSep 2, 2022
- BuyIRM$1K-$15KSep 2, 2022
More GILD insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.